Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Stockholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Keros Therapeutics, Inc. ("Keros" or "the Company") (NASDAQ:KROS). Investors who purchased Keros securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/KROS. Investigation […]

FTAI Aviation Ltd. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market SAN DIEGO, CA / ACCESS Newswire / January 27, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") proudly announces the granting of a pivotal invention patent in Japan (Patent No. 7619659) for its groundbreaking oral interferon formulation, VELDONA®,

Polestar Automotive Holding UK PLC (PSNY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Polestar Automotive Holding UK PLC ("Polestar" or "the Company") (NASDAQ:PSNY). Investors who purchased Polestar securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

Intellia Therapeutics, Inc. (NTLA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ:NTLA). Investors who purchased Intellia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NTLA.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bumble Inc. (BMBL) and Encourages Investors to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bumble Inc. ("Bumble" or "the Company") (NASDAQ:BMBL). Investors who purchased Bumble securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information

Bronstein, Gewirtz & Grossman, LLC Is Investigating Red Cat Holdings, Inc. (RCAT) And Encourages Investors to Connect

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Red Cat Holdings, Inc. ("Red Cat" or "the Company") (NASDAQ:RCAT). Investors who purchased Red Cat securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

Decarbonization-as-a-Service Market to Skyrocket at 97.1% CAGR, Reaching USD 19,960 Million by 2030 | Valuates Reports

Decarbonization-as-a-Service Market is Segmented by Type (Software, Service), by Application (Large Enterprises, SMEs). https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg The global Decarbonization-as-a-Service Market was valued at USD 170 Million in the year 2023 and is projected to reach a revised size of USD 19960 Million by 2030, growing at a CAGR of 97.1% during the forecast period. Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-3Q18784/Global_Decarbonization_as_a_Service_Market

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edison International (EIX) And Encourages Shareholders to Reach Out

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International ("Edison" or "the Company") (NYSE:EIX). Investors who purchased Edison securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EIX. Investigation Details

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TMDX.

Scroll to Top